Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

INTRODUCTION: Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. METHODS: In order to assess the mechanism of DFO, determ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Brain Behav
Main Authors: Fine, Jared M., Kosyakovsky, Jacob, Baillargeon, Amanda M., Tokarev, Julian V., Cooner, Jacob M., Svitak, Aleta L., Faltesek, Katherine A., Frey, William H., Hanson, Leah R.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://ncbi.nlm.nih.gov/pubmed/31960628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1536
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki